Immunotherapy leverages the body's immune system to fight cancer. Technological advancements have refined this approach through the development of CAR-T cell therapy, where a patient's T-cells are genetically engineered to target cancer cells. Additionally, AI algorithms predict which patients will benefit most from immunotherapy, based on their genetic and molecular profiles, thus personalizing and improving treatment outcomes.
